Beyond Air (XAIR) Short term Debt (2016 - 2026)

Beyond Air (XAIR) reported Short term Debt of $401000.0 for Q1 2026, down 34.15% on a YoY basis from $609000.0 in Q1 2025, and up 72.1% sequentially from $233000.0 in Q2 2025.

Beyond Air (XAIR) Short term Debt (2016 - 2026) Analysis & Trends

Beyond Air (XAIR) has 10 years of Short term Debt data on file, last reported at $401000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Short term Debt fell 34.15% year-over-year to $401000.0; the trailing twelve-month figure through Mar 2026 stood at $401000.0 (down 34.15% YoY), and the FY2026 full-year result was $401000.0, down 34.15% from the prior year.
  • Short term Debt climbed to $401000.0 in Q1 2026, from $233000.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $927000.0 in Q1 2022 to a low of $60000.0 in Q4 2022.
  • A 5-year average of $432533.3 and a median of $401000.0 in 2026 frame the typical range for Short term Debt.
  • Across the five-year window, Short term Debt jumped 121.43% in 2022 and sank 56.53% in 2025, its largest moves.
  • Tracing XAIR's Short term Debt over 5 years: stood at $60000.0 in 2022, then soared by 116.67% to $130000.0 in 2023, then plunged by 53.85% to $60000.0 in 2024, then jumped by 288.33% to $233000.0 in 2025, then jumped by 72.1% to $401000.0 in 2026.
  • Business Quant data shows XAIR's Short term Debt at $401000.0 in Q1 2026, $233000.0 in Q2 2025, and $609000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Beyond Air 2.25 Mn -10.02 Mn 94,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 401,000.00
Jun 30, 2025 233,000.00
Mar 31, 2025 609,000.00
Dec 31, 2024 60,000.00
Sep 30, 2024 258,000.00
Jun 30, 2024 536,000.00
Mar 31, 2024 800,000.00
Dec 31, 2023 130,000.00
Sep 30, 2023 275,000.00
Jun 30, 2023 495,000.00
Mar 31, 2023 775,000.00
Dec 31, 2022 60,000.00
Sep 30, 2022 310,000.00
Jun 30, 2022 619,000.00
Mar 31, 2022 927,000.00
Dec 31, 2021 30,000.00
Sep 30, 2021 140,000.00
Jun 30, 2021 349,165.00
Mar 31, 2021 557,000.00
Dec 31, 2020 1.05 Mn